Answers are grounded in this paper and cite their sources.
INTRODUCTION Congenital short bowel syndrome (CSBS) is a rare condition with high mortality. (1,2) Presumed to be of autosomal recessive inheritance, (3,4) the actual genetic defect responsible remains unknown. The limited information on long-term intellectual, nutritional, and quality of life outcomes in CSBS makes it difficult to counsel parents regarding therapy. As in children with surgical short bowel syndrome, children with CSBS have fat malabsorption and may require prolonged parenteral nutrition (5). Bacterial overgrowth is associated with longer duration of parenteral nutrition, compromised intestinal adaptation, and increased risk of liver disorders (6,7). We describe the excellent long-term nutritional and intellectual outcome of a patient with CSBS, with the aim of assisting families and health care providers of children with CSBS. CASE REPORT A 5-day-old female infant, born to unrelated German-American parents after a 38 week gestation, was transferred from an outside hospital with a history of bilious emesis and a barium upper gastrointestinal series suggestive of malrotation. The pregnancy had been uneventful, birth weight was 2.8 kg, and the perinatal course was benign. A female sibling born before this patient had died at 6 weeks of age from malrotation and midgut volvulus. On admission, the baby appeared slightly malnourished. An abdominal radiograph showed barium in the colon, confirming the position of the cecum in the left upper quadrant. Laparotomy revealed a shortened bowel measuring approximately 30 cm, with malrotation but no volvulus. Ladd bands were divided, an appendectomy was performed, and the bowel repositioned with the duodenum in the right gutter and the colon left of the midline. Postoperatively, the baby had diarrhea and frequent emesis on a fortified elemental formula, and her weight decreased to 2.5 kg by 7 days of age. Stools tested for reducing substances were negative, although neutral fats and fatty acids were seen on microscopic stool examination. Intestinal biopsies obtained during upper intestinal endoscopy were normal. Because of continued bilious vomiting, poor weight gain, and suspicion that there was an inherent intestinal dysmotility, a central intravenous line and gastrostomy tube were placed at 18 days of age. Parenteral nutrition was administered, and Pregestimil (Mead Johnson, Evansville, IN) was given enterally in small boluses during the day and by gastrostomy drip at night. Treatment with Cisapride (Janssen Pharmaceutica, Titusville, NJ) 1 mg orally three times per day was associated with a decrease in frequency of emesis from two or three episodes per day to only rare emesis at night. Weight gain improved. At 1 month and 9 days of life, the child was discharged to the care of her parents and has been followed for 7 years at our center (Fig. 1).FIG. 1: Our patient at approximately age 5 years old. Minor dysmorphic features include prominent cupped shaped ears with small attached lobes, prominent nasal bridge with small nose, and long digits.Parenteral nutrition support was weaned gradually and discontinued at 22 months of age. Enteral feeds by way of gastrostomy were discontinued at 32 months. During the period of gradually increasing oral feedings, the child vomited upon awakening approximately three times a week. She regularly had two to four soft stools per day. Liver function tests remained normal. She did not receive milk products because of a clinical suspicion of milk protein allergy. A single episode of sepsis occurred while her central intravenous line was in place. Staphylococcus epidermidis was cultured from the central venous catheter but not from peripheral blood, and the central venous catheter was not removed. Cisapride was discontinued at 24 months of age. METHODS Digestive Function Testing Studies of digestive function in this patient were performed both at 10 and 11 months of age as part of a larger study of bacterial overgrowth in children with short bowel syndrome and its treatment. Studies were conducted according to an approved protocol at The Children's Hospital on the Pediatric General Clinical Research Center. Informed consent was obtained from the parents at the time of this study (8). At 10 and 11 months, a 3 day fecal fat collection was performed simultaneous with calculation of total enteral calorie and fat intake. Fractional fecal excretion of dietary fat was calculated from estimated dietary fat intake and quantitative fecal fat analysis using nuclear magnetic resonance spectroscopy (Mayo Clinic Reference Laboratory, Rochester, MN). Fat excretion in term newborns may be as high as 15% and decreases with age to approximately 7% (9). As a measure of intestinal bacterial overgrowth, fasting and serial 15 minute breath hydrogen content was measured after a 1 gr/Kg oral glucose load. We defined an increase of 10 ppm in exhaled hydrogen 30 minutes after glucose ingestion to be suggestive of bacterial overgrowth. Stool cultures for aerobic and anaerobic organisms were performed on frozen aliquots of stool. Duodenal fluid was obtained for quantification of total aerobic and anaerobic organisms. Fasting duodenal samples in this patient were obtained by intubation of the gastrostomy with a sterile 8 F feeding tube advanced under fluoroscopic guidance into the descending duodenum. More than 105 aerobic colony forming units (CFU)/mL of enteric juice were considered evidence for bacterial overgrowth of the small bowel (7,10). After the initial digestive testing, a lyophilized preparation of 1.5 × 1010 CFU Lactobacillus casei GG (CAG Functional Foods, a division of ConAgra Foods, Inc., Omaha, NE) was administered twice daily suspended in formula for 30 days. Bile acids in both the fasting duodenal aspirates and sera were evaluated by Dr. Ken Setchell, Cincinnati, Ohio. One month after initiating therapy with Lactobacillus casei GG, stools were cultured at ConAgra Foods Laboratories in Omaha NE. Neurocognitive Testing The patient's intellectual ability was assessed with the Wechsler Intelligence Scale for Children-IV (WISC-IV, The Psychological Corp., San Antonio, TX) at 7.5 years of age. Perceptual reasoning, verbal comprehension, working memory, and processing speed indexes were determined. Academic and social skills were evaluated. RESULTS Digestive Function Results In both assessments, approximately 40% of calories were received in parenteral nutrition fluids and 60% by enteral/oral nutrition. The coefficient of fat excretion was 33% of intake before and 24% of intake 1 month after treatment with Lactobacillus GG (Table 1). Reducing substances were not detected in the stool.TABLE 1: Digestive studies before and after 1 month of Lactobacillus GG (LGG) treatment at age 10 monthsFasting breath hydrogen both at 10 and 11 months of age was 3 ppm and was 4 to 5 ppm 30 minutes after glucose ingestion. Quantitative cultures of duodenal fluid and stool before and after treatment produced 105 CFU/mL or greater aerobes, both Gram-positive cocci and coliforms. No anaerobes were detected. The 11 month stool sample evaluated at the ConAgra laboratories were colonized with Lactobacillus casei GG organisms. Total serum bile acids before and after therapy were 8.3 and 13.3 μmol/L, respectively, with approximately 90% unconjugated bile acids at both measurements. Total bile acids in duodenal bile at 10 and 11 months were 830 μmol/L and 3,329 μmol/L, respectively. Unconjugated bile acids were also the predominant form in duodenal aspirates, comprising approximately 50% of each sample. Growth and Nutrition The patient's weight and length have been maintained since birth around the 75th percentile for age (Fig. 2). Laboratory assessment of nutritional status is shown in Table 2. The plasma zinc concentration has persisted in the low or low normal range.TABLE 2: Biochemical studiesFIG. 2: Growth curve of our patient showing steady growth in the normal range.Neurocognitive Testing The patient's intellectual ability at 7.5 years as assessed by the WISC-IV is intact. The Full Scale IQ is 120 (90th percentile). Perceptual problem solving skills are especially strong with a Perceptual Reasoning Index of 121. Verbal Comprehension Index is 112. She manipulates verbal information with facility and good attention, with a Working Memory Index of 116, and makes rapid and accurate visual judgments, with a Processing Speed Index of 115. Visual motor skills were relatively weak but did not cause any functional difficulties. Academic and social skills are intact. DISCUSSION We report a patient with CSBS, a rare disorder often diagnosed in early infancy and associated with malrotation. This child's nutritional and intellectual outcome has been excellent. Reported mortality in CSBS is as high as 88% (2). Mortality is related to shortness of residual intestine, associated major malformations, as well as to complications of prolonged parenteral nutrition (11,12). Associated anomalies reported in CSBS include ectopic anus and cystically dilated colon (13), dysmotility (3), dextrocardia and asplenia, (14) and pyloric hypertrophy (15). Abnormalities in chromosome 4 (14) and the X chromosome (15) have been reported. To our knowledge, a locus has not been identified for isolated familial CSBS, the form which our patient appears to have. In pediatric short bowel syndrome (not just CSBS), factors associated with outcome include intestinal length, ability to tolerate enteral feeds in the first few months of life, frequency of infection, breast milk, and use of casein hydrolysate formula (16,17). Bacterial overgrowth is associated with adverse outcome (6,7). Our patient had a very short residual small intestine (30 cm compared with normal term infant length of 190-280 cm) (18-20) and had convincing evidence of bacterial overgrowth using deconjugated serum and duodenal bile acids as the gold standard. Despite the apparent bacterial overgrowth, she tolerated feedings well, never had significant cholestasis, and had only one infection of her central venous catheter. The inability of duodenal culture and breath hydrogen to confirm the results of bile acid analysis points out the problems with accurate diagnosis of bacterial overgrowth. Duodenal samples for anaerobes must be collected and cultured under the strictest conditions to prevent oxygen contamination. Breath hydrogen testing depends on numerous factors unrelated to small bowel overgrowth, including gastric motility, small bowel transit, resident flora, and difficulty in obtaining uncontaminated breath samples in young children. Any of these factors could impact results. Lactobacillus GG and other probiotics are attractive therapies for short bowel syndrome (10) because they may decrease the number of potentially pathogenic luminal bacteria and improve intestinal inflammation (7). However, lactobacillus GG did not appear to affect our patient. In fact, the outcome of our patient is quite similar to a patient with CSBS reported by Dorney et al. (5) in 1986. In both patients, parenteral nutrition was discontinued around age 2 years, fat excretion was increased, and growth and intellectual functioningwere normal. Despite a much shorter intestine than in the patient reported by Dorney et al. (30 vs. 69 cm), our patient did not show carbohydrate malabsorption and has not required B12 supplementation. Our patient did not require small bowel transplantation. The diagnosis of CSBS itself should not be considered an indication for small bowel transplantation. However, complications such as progressive cholestasis associated with parenteral nutrition, loss of central venous access, and recurrent sepsis events may lead to small bowel transplantation in children with CSBS (21). CSBS is a serious condition that requires a multidisciplinary approach for survival and to avoid the need for small bowel transplantation. In summary,we report the favorable nutritional and intellectual outcome of a child with CSBS despite a very short intestine and bacterial overgrowth. By age 3 years, parenteral and enteral nutrition were discontinued. Growth and formal intellectual testing results are normal. Although the bulk of the literature suggests high mortality and poor outcome, we hope this case emphasizes the spectrum of outcomes and is of help in those caring for children with CSBS.
No takes yet. Share an insight, caveat, or question.
Ordonez et al. (2006) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: